英文别名:
Lazertinib mesilate hydrate;UNII-WUT449BEG5;Lazertinib mesylate (USAN);Lazertinib mesilate hydrate (JAN);R-605024;2411549-88-5;SCHEMBL31190278;Lazcluze (TN);Lazertinib mesilate hydrate [JAN];Lazertinib Mesylate;LAZERTINIB MESYLATE [USAN];Lazertinib mesylate monohydrate [WHO-DD];RefChem:201446;2-Propenamide, N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phenyl]-, methanesulfonate, hydrate (1:1:1);JNJ-73841937-ZCY;YH25448AM;WUT449BEG5;N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide methanesulfonate hydrate;2-Propenamide, N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)-, methanesulfonate, hydrate (1:1:1);R605024;D12245;Lazertinib mesylate monohydrate;
Inchi:
1S/C30H34N8O3.CH4O3S/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21;1-5(2,3)4/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34);1H3,(H,2,3,4)